Critical Healthcare-acquired Infections Expo comes to Las Vegas to Address C.difficile Concerns and Patient Risks

LAS VEGAS, Nev. — The C Diff Foundation welcomes Dale Gerding, MD, FACP, FIDSA, and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois and Research Physician at the Edward Hines Jr. VA Hospital as Conference Chair of the upcoming 5th Annual International “C.diff. Awareness Conference and Health EXPO,” taking place on Nov. 9 and 10, 2017 at the University of Nevada – Las Vegas, Thomas and Mack Center, 2nd Floor Pavilion.

Infinity Treatment Centers Achieve the Highest of Safety and Quality Standards in Substance Abuse and Behavioral Disorder Treatment

MALIBU, Calif. — Infinity Treatment Centers, a leader in the treatment of addiction and co-occurring disorders announced today that they had earned The Joint Commission’s Gold Seal of Approval by demonstrating clinical excellence and compliance with performance standards. Infinity Treatment Centers underwent a demanding clinical evaluation to obtain Joint Commission Accreditation.

Edmond Hooker, MD, Darrel Hicks, and Bruce Rippe Discuss Medical Mattress Contamination Issues on C.diff Spores and More, Aug. 1

TAMPA, Fla. — C Diff Foundation’s, “C. diff. Spores and More Global Broadcasting Network,” is honored to announce Dr. Edmond Hooker, MD – Associate Professor of Health Services Administration at Xavier University, Darrel Hicks, a well-known hospital environment specialist and educator, and Bruce Rippe, CEO of Trinity Guardion, manufacturer of the Trinity Guardion Patient Protective Barrier, as our guest speakers on August 1, 2017.

Dr. Harte and the ‘Health Care’ Debate – A Loss of Health AND Liberty

CORTE MADERA, Calif. — Dr. Don Harte, noted chiropractic activist and former Libertarian State Senate candidate, is offended by the current debate on so-called “health care,” and thinks that you should be, too. “This is a created, an imagined problem of government being responsible for propping up an already highly profitable industry – Medicine,” according to Dr. Harte.

Clifford McDonald, MD and Alison Laufer-Halpin, Ph.D., of the CDC Discuss the Human Microbiome on C. diff. Spores and More

ATLANTA, Ga. — C Diff Foundation’s “C. diff. Spores and More Global Broadcasting Network” is honored to announce Doctors McDonald and Laufer-Halpin as our guest speakers on July 25, 2017 at 10 a.m. PT / 1 p.m. ET on C Diff Radio.

The Everest Foundation Helps to Fund Medical Residency Positions and Fund Research at Teaching Hospitals

LOS ANGELES, Calif. — It has been an enormously successful year for almost two dozen Everest Foundation Scholars who are actively working on research projects for submission and hopeful publication in esteemed medical journals as well as starting their medical residency training in coveted ACGME Accredited residency programs across the U.S.

Nationally Renowned Research Doctor Will Discuss His New Hopes, Methods, and Successes with Treating Rare Children’s Cancers on Nov. 5, 2017

LAKE FOREST, Calif. — Jareds Juggernaut To Cure Sarcoma, a non-profit which funds researchers of body sparing cancer treatments targeted for rare children’s cancers, today announced an event which features Dr. Charles Keller as the keynote speaker, which will take place on November 5, 2017 in the Sun and Sail Club in Lake Forest, Calif.

C Diff Foundation Announces Scholarship Program to Support Health Care Students

TAMPA, Fla. — The C Diff Foundation is pleased to announce the Michael and Helen Caralla, Sr. Educational Scholarship program. The scholarship program is to help health care students succeed and reach their educational goals.

ChemDiv Selected by Arcus Biosciences as the Sole Chemistry Provider for its Discovery Screening Collection

SAN DIEGO, Calif. — ChemDiv Inc., a fully integrated California-based CRO, announced today that Arcus Biosciences selected ChemDiv as the sole source of molecules for Arcus’s growing HTS screening collection. This collaboration, which utilized Arcus’s medicinal chemistry knowledge and ChemDiv’s computational and synthetic chemistry expertise, has resulted in the selection of several hundred thousand structures from which Arcus expects to identify starting points for several of the discovery programs in its portfolio.

Verify Smart Corporation Signs Letter of Intent to Acquire Equity Stake and Exclusive International Reseller Rights in Med-Con Technologies, LLC

FERNLEY, Nev. — Verify Smart Corporation (OTC:VSMR / OTCMKTS:VSMR) a Global innovator in financial fraud prevention and digital distribution solutions announced today that it has signed a Letter of Intent to acquire an equity stake and exclusive international reseller rights in Med-Con Technologies, LLC for cash and stock.